Category: Webinar Archive
Small registries making the difference – The Dutch Matchis experience
Challenges of HLA matching in a diverse population and how the HLA community can help
An epigenetic biomarker that predicts treatment success and allows personalized management in Crohn’s disease
HLA gene-editing of DRβ1_04_01 – A therapy for rheumatoid arthritis
Immunogenetics of KIR and their interactions with HLA class I
Chimerism testing with high sensitive qpcr: implications for the routine work and clinicians
Population study of the province of Quebec through the lens of the Registry
The importance of stem cell donation (Amsterdam session)
The importance of stem cell donation (Chicago session)
MICA is a novel Histocompatibility antigen in kidney transplantation
Webinar – HLA dogmas True or False
Webinar – Accurate Blood Group Typing
Webinar – Understanding swine histocompatibility & immunogenetics
Webinar – Molecular HLA compatibility background, theory and application
The changing perspectives on uterine immunity
HLA Typing with PacBio – Achieving high quality results with a long read sequencer
Somatic Mutation of HLA Genes in Blood Cancer
New findings on the HLA-related MR1 gene
PIRCHE Epitope Matching in Kidney Transplantation: A Case Study
New insights from high-resolution KIR sequencing in neurological disease
Significance and detection of chimerism after hematopoietic stem cell transplantation
Transitioning to NGS: Why, and what to consider?
with Deborah Tsuyuki PhD, Technical Application Specialist at GenDx.
Towards defining the immunogenicity of HLA eplets
Epitope-based HLA-matching has emerged as a promising strategy to improve solid organ transplant (SOT) outcome. Functional units of HLA epitopes are called ‘eplets’. Mismatched eplets on donor HLA can be defined be comparing the tertiary protein structure of donor- and recipient-HLA, on the basis of 2-field HLA typing results.
An unmet need so far is the definition of the immunogenicity of each individual eplet. Our research group in Basel/Switzerland has investigated the immunogenicity of eplets using the human pregnancy as a model.
The two speakers discuss current concepts to define the immunogenicity of HLA eplets and share their experiences from their own study.
Daily practice in an HLA lab: dealing with HLA-DR, a complicated genetic region
with guest speaker Dr. Brown, the associate director of the histocompatibility testing laboratory, and assistant professor of pathology and laboratory medicine, at the University of Pennsylvania.
Variability in HLA expression: Impact on histocompatibility assay interpretation and immunologic risk assessment
with guest speaker Dr. Luis Hidalgo, associate Professor and Histocompatibility Lab Director at the University of Wisconsin School of Medicine and Public Health.
PIRCHE – Predicting Alloreactivity in Transplantation and Transfusion
with guest speaker Dr Eric Spierings, Universitair Medisch Centrum Utrecht, NL.
Monitoring HLA-loss at time of leukemia relapse after stem cell transplantation
with guest speaker Prof. Katharina Fleischhauer, Universitatsklinikum Essen, DE